Editorial: Mesenchymal and induced-pluripotent stem cells as models to study biological processes

Melvin A Ambele; Catarina O Miranda

doi:10.3389/fgene.2024.1439306

Editorial: Mesenchymal and induced-pluripotent stem cells as models to study biological processes

Front Genet. 2024 Jul 25:15:1439306. doi: 10.3389/fgene.2024.1439306. eCollection 2024.

Authors

Melvin A Ambele^{1

2}, Catarina O Miranda^{3

4

5

6}

Affiliations

¹ Department of Immunology, Institute for Cellular and Molecular Medicine, SAMRC Extramural Unit for Stem Cell Research and Therapy, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
² Department of Oral and Maxillofacial Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
³ CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal.
⁴ CIBB- Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
⁵ III-Institute for Interdisciplinary Research, University of Coimbra, Coimbra, Portugal.
⁶ GeneT, Center for Excellence in Gene Therapy in Portugal, University of Coimbra, Coimbra, Portugal.

No abstract available

Keywords: biological processes; disease models; induced-pluripotent stem cells; mesenchymal stromal/stem cells; organoids.

Publication types

Editorial

Grants and funding

The authors declare that financial support was received for the research, authorship, and/or publication of this article. MAA is funded by the NHLS Research Trust Pathology Research Award (GRANT004_94920), National Research Foundation grant no. 114044 and South African Medical Research Council (Grant No. A1A982). COM is funded by the ERDF through the Regional Operational Program Center 2020, Competitiveness Factors Operational Program (COMPETE 2020), and National Funds through FCT (Foundation for Science and Technology)—BrainHealth2020 projects (CENTRO-01-0145-FEDER-000008), UID/NEU/04539/2019, UIDB/04539/2020, UIDP/04539/2020, LA/P/0058/2020, 2022.06127.PTDC, ViraVector (CENTRO-01-0145- FEDER-022095), CortaCAGs (PTDC/NEU-NMC/0084/2014|POCI-01-0145-FEDER-016719), SpreadSilencing POCI-01-0145-FEDER-029716, Imagen POCI-01-0145-FEDER-016807, Interdisciplinary Scientific Research Seed Projects (University of Coimbra), 2022.06127.PTDC, CancelStem POCI-01-0145-FEDER-016390, POCI-01-0145-FEDER- 032309, ARDAT under the IMI2 JU Grant agreement No 945473 supported by EU and EFPIA; GeneT—Teaming Project 101059981 supported by the European Union’s Horizon Europe program; as well as SynSpread, ESMI and ModelPolyQ under the EU Joint Program—Neurodegenerative Disease Research (JPND), the last two co-funded by the European Union H2020 program, GA No.643417; by National Ataxia Foundation (USA), the American Portuguese Biomedical Research Fund (APBRF) and the Richard Chin and Lily Lock Machado-Joseph Disease Research Fund.